In vivo activation of lymphokine-activated killer activity with interleukin-2: prospects for combination therapies.

Sosman JA, Hank JA, Sondel PM
Semin Oncol. 1990 17 (1 Suppl 1): 22-30; discussion 38-41

PMID: 2405492

MeSH Terms (12)

Antibodies, Monoclonal Blood Transfusion Combined Modality Therapy Humans Immunization, Passive Interferon Type I Interleukin-2 Killer Cells, Lymphokine-Activated Lymphocyte Activation Neoplasms Recombinant Proteins Time Factors

Connections (1)

This publication is referenced by other Labnodes entities: